References
Original article
Harrison, S. A. et al. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nat. Med. https://doi.org/10.1038/s41591-023-02603-1 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ray, K. Resmetirom safe for nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 21, 2 (2024). https://doi.org/10.1038/s41575-023-00874-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-023-00874-0
- Springer Nature Limited